… community-acquired pneumonia. Therefore, corticosteroids as adjuvant therapy are
increasingly valued by the investigators but the therapeutic efficacy is still controversial. For severe …

… jirovecii pneumonia, corticosteroid treatment was … on the management of community-acquired
pneumonia in adults[J]. Clin … Efficacy and safety of recombinant human activated protein …

… vere community acquired pneumonia and severe hospital acquired … Efficacy and safety
of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an …

… pneumoniae pneumonia(MPP) is one of the most common types of community acquired
pneumonia(CAP… Efficacy of glucocorticoids for the treatment of macrolide refractory Mycoplasma …

… To discuss pathogenic bacteria distribution and risk factors in community acquired pneumonia
complicated with infection of gram negative bacteria, and to reduce the infection rate. …

… To investigate the clinical efficacy of cefoperazone sodium … Corticosteroids as adjunctive
treatment to antibiotics[J]. … in the management of bacterial community-acquired pneumonia [J]. …

… Corticosteroid therapy for critically ill patients with middle east respiratory syndrome[J]. Am
J … Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J]. …

… improve the clinical efficacy and the lung function in the treatment of patients with severe
pneumonia. It … Risk factors and coping strategies of severe community-acquired pneumonia in …

… the efficacy and safety of rituximab (RTX) in the treatment of … patients experienced
community-acquired pneumonia and 2 … sequential treatment with tacrolimus-tituximab versus …

… Efficacy and safety of adjunctive corticosteroids therapy for patients with severe
community-acquired pneumonia: A systematic review and meta-analysis [J]. Medicine, 2019, 98 (13): …